A forum for researchers, students and applicants in the field of cyclodextrin technology
Cyclarity Therapeutics, Inc., a clinical stage biopharmaceutical company engineering cyclodextrin molecules into simple, scalable, and affordable therapies that bind and
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
Ischemic stroke is one of the main causes of long-term morbidity/mortality and early treatment of stroke is key issue. Xenon
Globally, more than 67 million people are living with the effects of ischemic stroke. Importantly, many stroke survivors develop a
